SAS-6 coordinates cell-matrix and cell-cell interactions to promote cancer cell migration

Cancer's most deadly trait is not the growth of a tumor, but its ability to spread. When cancer cells break away from their original site and travel through the body to settle in new organs, the disease becomes much harder to treat. This journey, known as metastasis, relies entirely on the cell's ability to move. To migrate, a cell must change its shape, push against its surroundings, and let go of its neighbors to pull itself forward. It is a complex physical process that requires the cell to coordinate its internal skeleton with the external world. At the heart of this movement are tiny structures inside the cell called centrioles. These are small, barrel-shaped organelles that help organize the cell's internal scaffolding and often act as the base for a hair-like antenna called a cilium, which senses the environment. When these structures malfunction, cells can lose their direction or their ability to stick and move correctly, a problem frequently seen in aggressive cancers.

Researchers at Brunel University of London have now uncovered a specific protein that acts as a crucial coordinator for this movement. The protein, named SAS-6, is a fundamental building block of centrioles. In a new study, the team investigated how SAS-6 influences the ability of cancer cells to travel through a realistic, three-dimensional environment that mimics the tissue they would encounter in a human body. They focused on a type of lung cancer known as small cell lung cancer, which is particularly aggressive and prone to spreading. By manipulating the levels of SAS-6 in these cells, the scientists discovered that this single protein is essential for the cell to maintain its shape, form proper connections with its neighbors, and move efficiently. When SAS-6 was removed, the cells became confused, losing their sense of direction and struggling to migrate. When SAS-6 was added in excess, the cells moved faster and further. This suggests that SAS-6 does more than just build the cell's internal machinery; it actively helps the cell decide where to go and how to interact with the world around it.

To test these ideas, the researchers created a custom environment for the cells to move through. Instead of using flat glass slides or artificial gels that do not fully represent human tissue, they grew a "cell-derived matrix." They started with healthy fibroblast cells, which are the body's natural tissue builders, and let them grow for eight days. These cells secreted their own natural proteins and fibers, creating a complex, web-like structure. The researchers then removed the living cells, leaving behind only the matrix they had built. This created a realistic, three-dimensional landscape for the cancer cells to navigate. They then placed two types of lung cancer cells onto this matrix: one group with normal levels of SAS-6 and another group where the SAS-6 protein had been genetically silenced. They watched these cells move over a period of sixteen hours, tracking their paths and speed with high-resolution cameras.

The results were striking. The cancer cells that had their SAS-6 removed moved significantly slower and covered much shorter distances than the normal cells. They also looked different. While the healthy-moving cells stretched out into long, streamlined shapes, the SAS-6-depleted cells remained round and clumped together, failing to extend the leading edges needed to pull themselves forward. When the researchers looked closer at the internal structures of these struggling cells, they found that the cells had lost their front-and-back orientation. A moving cell needs a clear front to push against the environment and a rear to let go. Without SAS-6, the cells seemed to push and pull in all directions at once, like a person trying to walk while pushing against walls on every side. This lack of direction was accompanied by a chaotic arrangement of the cell's internal fibers and an excessive number of sticky points, called focal adhesions, that anchored the cell to the matrix. Instead of releasing these anchors to move forward, the SAS-6-depleted cells held on too tightly, trapping themselves in place.

The study also revealed a surprising connection between the cell's movement and its ability to stick to other cells. Cancer cells often travel in groups, and they rely on strong connections with their neighbors to move collectively. The researchers found that when SAS-6 was removed, the cells lost their ability to form these strong bonds. A specific protein called ZO-1, which acts like a seal between cells to keep them tightly joined, was significantly reduced in the SAS-6-depleted cells. The cells became scattered and disorganized, unable to maintain the tight clusters seen in the control group. This suggests that SAS-6 plays a dual role: it helps the cell organize its own internal machinery to move, and it also helps the cell maintain the structural integrity of its connections with neighboring cells. The researchers noted that the protein SAS-6 appears to work in concert with ZO-1, linking the internal movement machinery with the external social structure of the cell group.

To confirm that these findings were not just a fluke of one specific cell type, the team also tested the opposite scenario. They took a different type of cell and forced it to produce too much of a stable version of SAS-6. In this case, the cells moved faster and traveled further than usual, reinforcing the idea that the amount of SAS-6 directly controls the speed and distance of migration. The researchers also observed that the SAS-6 protein is found at the base of the cilia, the sensory antennas on the cell surface. When SAS-6 was removed, the number of these cilia dropped, and the cells lost their ability to sense their environment effectively. This loss of sensory input likely contributes to the confusion in movement, as the cells cannot properly read the signals that tell them which way to go.

The implications of these findings extend beyond just understanding how a single protein works. The study highlights that the machinery responsible for building centrioles is deeply integrated with the processes of cell movement and cell-to-cell communication. In many aggressive cancers, including lung, breast, and colorectal cancers, SAS-6 is often found in higher-than-normal amounts. This new research suggests that this overabundance might be a driving force behind the rapid spread of these tumors. By making cells move faster and more aggressively, high levels of SAS-6 could be a key factor in metastasis. Conversely, the study shows that reducing SAS-6 can slow down this movement, suggesting that targeting this protein could be a viable strategy to stop cancer from spreading. The researchers propose that SAS-6 acts as a central coordinator, balancing the cell's attachment to the surrounding tissue with its need to detach and move forward. Without this balance, the cell either gets stuck or moves aimlessly.

This work provides a clearer picture of the physical and molecular rules that govern how cancer cells invade new territories. It moves the conversation beyond simple genetic mutations to the actual physical behavior of the cell. By showing that a single protein can dictate whether a cell moves with purpose or gets lost in its own confusion, the study offers a new perspective on how metastasis occurs. The use of the cell-derived matrix was crucial, as it allowed the researchers to see these behaviors in a setting that closely resembles the human body, rather than in a simplified laboratory dish. The findings suggest that the journey of a cancer cell is not just a matter of breaking free, but of carefully managing its internal structure and its relationships with other cells. As scientists continue to explore the role of SAS-6, it may become a valuable target for therapies designed to keep cancer cells in place, preventing them from reaching the vital organs where they cause the most harm.